349 related articles for article (PubMed ID: 34268343)
1. Cost-Effectiveness Analysis of Direct Oral Anticoagulants Vs. Vitamin K Antagonists in the Elderly With Atrial Fibrillation: Insights From the Evidence in a Real-World Setting.
Wu Y; Zhang C; Gu ZC
Front Cardiovasc Med; 2021; 8():675200. PubMed ID: 34268343
[No Abstract] [Full Text] [Related]
2. Cost-Effectiveness of Direct Non-Vitamin K Oral Anticoagulants Versus Vitamin K Antagonists for the Management of Patients with Non-Valvular Atrial Fibrillation Based on Available "Real-World" Evidence: The Italian National Health System Perspective.
Lorenzoni V; Pirri S; Turchetti G
Clin Drug Investig; 2021 Mar; 41(3):255-267. PubMed ID: 33587284
[TBL] [Abstract][Full Text] [Related]
3. Economic Evaluation of Direct Oral Anticoagulants Compared to Warfarin for Venous Thromboembolism in Thailand: A Cost-Utility Analysis.
Niyomsri S; Nimworapan M; Wongcharoen W; Dilokthornsakul P
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833871
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation Therapy for Atrial Fibrillation in Patients With Alzheimer's Disease.
Ruiz Vargas E; Sposato LA; Lee SAW; Hachinski V; Cipriano LE
Stroke; 2018 Dec; 49(12):2844-2850. PubMed ID: 30571418
[TBL] [Abstract][Full Text] [Related]
5. Updating the Cost Effectiveness of Oral Anticoagulants for Patients with Atrial Fibrillation Based on Varying Stroke and Bleed Risk Profiles.
Wang CY; Pham PN; Thai TN; Brown JD
Pharmacoeconomics; 2020 Dec; 38(12):1333-1343. PubMed ID: 32924092
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation at high risk of bleeding and normal kidney function.
Hernandez I; Smith KJ; Zhang Y
Thromb Res; 2017 Feb; 150():123-130. PubMed ID: 27771008
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of Direct Oral Anticoagulant vs. Warfarin Among Atrial Fibrillation Patients With Intermediate Stroke Risk.
Choi JH; Kim W; Kim YT; Cho J; Shin SY; Kim C; Kim JB
Front Cardiovasc Med; 2022; 9():849474. PubMed ID: 35479283
[TBL] [Abstract][Full Text] [Related]
9. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.
López-López JA; Sterne JAC; Thom HHZ; Higgins JPT; Hingorani AD; Okoli GN; Davies PA; Bodalia PN; Bryden PA; Welton NJ; Hollingworth W; Caldwell DM; Savović J; Dias S; Salisbury C; Eaton D; Stephens-Boal A; Sofat R
BMJ; 2017 Nov; 359():j5058. PubMed ID: 29183961
[No Abstract] [Full Text] [Related]
10. Cost-Effectiveness of Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation in Hong Kong.
Peng K; Li Y; Chan EW; Wong ICK; Li X
Value Health Reg Issues; 2023 Jul; 36():51-57. PubMed ID: 37030031
[TBL] [Abstract][Full Text] [Related]
11. Safety outcomes of direct oral anticoagulants in older adults with atrial fibrillation: a systematic review and meta-analysis of (subgroup analyses from) randomized controlled trials.
Doni K; Bühn S; Weise A; Mann NK; Hess S; Sönnichsen A; Salem S; Pieper D; Thürmann P; Mathes T
Geroscience; 2024 Feb; 46(1):923-944. PubMed ID: 37261677
[TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness of Apixaban versus Other Direct Oral Anticoagulants and Warfarin in the Prevention of Thromboembolic Complications Among Finnish Patients with Non-Valvular Atrial Fibrillation.
Hallinen T; Soini E; Asseburg C; Linna M; Eloranta P; Sintonen S; Kosunen M
Clinicoecon Outcomes Res; 2021; 13():745-755. PubMed ID: 34413661
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness Analysis of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Thai Patients With Non-Valvular Atrial Fibrillation.
Dilokthornsakul P; Nathisuwan S; Krittayaphong R; Chutinet A; Permsuwan U
Heart Lung Circ; 2020 Mar; 29(3):390-400. PubMed ID: 31000364
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Direct Oral Anticoagulants Compared to Warfarin in Prevention of Thromboembolic Events Among Elderly Patients with Atrial Fibrillation.
Kailas SD; Thambuluru SR
Cureus; 2016 Oct; 8(10):e836. PubMed ID: 27900231
[TBL] [Abstract][Full Text] [Related]
15. Direct Oral Anticoagulants vs. Vitamin K Antagonists in Atrial Fibrillation Patients at Risk of Falling: A Meta-Analysis.
Gao X; Huang D; Hu Y; Chen Y; Zhang H; Liu F; Luo J
Front Cardiovasc Med; 2022; 9():833329. PubMed ID: 35615562
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of dabigatran versus vitamin K antagonists for the prevention of stroke in patients with atrial fibrillation: a French payer perspective.
Chevalier J; Delaitre O; Hammès F; de Pouvourville G
Arch Cardiovasc Dis; 2014; 107(6-7):381-90. PubMed ID: 24973113
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of left atrial appendage closure with Watchman for non-valvular atrial fibrillation patients in Japan.
Kamae I; Zhong Y; Hara H; Inoue K; Yasaka M; Reddy VY; Holmes DR; Sakurai M; Gavaghan MB; Amorosi SL; McGovern AM; Priest V; Inoue S; Shibahara H; Akehurst RL
J Med Econ; 2023; 26(1):1357-1367. PubMed ID: 37819734
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients.
Shah A; Shewale A; Hayes CJ; Martin BC
Stroke; 2016 Jun; 47(6):1555-61. PubMed ID: 27103018
[TBL] [Abstract][Full Text] [Related]
19. Comparison of effectiveness and safety of direct oral anticoagulants versus vitamin-k antagonists in elderly patients with atrial fibrillation: a systematic review and cost-effectiveness analysis protocol.
Wang N; Shen NN; Wu Y; Zhang C; Pan MM; Qian Y; Gu ZC
Ann Transl Med; 2020 Mar; 8(6):391. PubMed ID: 32355835
[TBL] [Abstract][Full Text] [Related]
20. Comparison of major bleeding risk in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants in the real-world setting: a network meta-analysis.
Deitelzweig S; Farmer C; Luo X; Li X; Vo L; Mardekian J; Fahrbach K; Ashaye A
Curr Med Res Opin; 2018 Mar; 34(3):487-498. PubMed ID: 29188721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
